+ 7.05
+ 2.21%
+ 4.00
+ 1.18%
+ 6.32
+ 1.54%
+ 1.27
+ 0.94%
+ 1.54
+ 0.9%

Analyzing The Price Action In Artelo Biosciences Stock Today

February 12, 2021 9:54 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

The Price And Volume Action In Artelo Biosciences's Stock Today

Artelo Biosciences's (NASDAQ:ARTL) stock has been rising Friday, up 106.12% to a price of $3.29. Friday the stock has been traded at a volume of 51.68 million, about 713.6% of its recent 30-day volume average of 7.25 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Artelo Biosciences shares are trading higher after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a $7 price target.

Further Analysis of Recent Price Action

The moving average price of the stock over the past 50 days was $0.9 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $2.13 and as low as $0.45.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.


Movers Trading Ideas

Related Articles

12 Health Care Stocks Moving In Monday's Pre-Market Session

  read more

24 Stocks Moving in Monday's Pre-Market Session

Gainers InspireMD, Inc. (NYSE: NSPR) rose 29.3% to $0.53 in pre-market trading. InspireMD, last week, announced a 1-for-15 reverse split of its common stock effective April 26. read more

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up 0.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $27.7 million. read more

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers read more